Clozapine and all ‐cause mortality in treatment‐resistant schizophrenia: a historical cohort study

ConclusionsClozapine reduces the risk of mortality in patients who meet criteria for TRS. We provide further evidence that improving access to clozapine in TRS is likely to reduce the mortality gap in schizophrenia.This article is protected by copyright. All rights reserved.

Source: Acta Psychiatrica Scandinavica - November 26, 2018 Category: Psychiatry Authors: Jaelim Cho, Richard D. Hayes, Amelia Jewell, Giouliana Kadra, Hitesh Shetty, James H. MacCabe, Johnny Downs Tags: Original Article Source Type: research